AUA annual meeting featured the 4 th annual IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder ...

Mr. Connor and his team at Vanderbilt designed, manufactured, and evaluated a stone retrieval device with an independently ...

Stabilized hyaluronic acid is increasingly used as a rectal spacer to reduce radiation related gastrointestinal side effects in prostate cancer treatment. Rectal wall infiltration is uncommon but a ...

Sasanlimab, a subcutaneously administered PD-1 inhibitor, in combination with BCG represents the first potential treatment advancement for BCG-naïve, high-risk non-muscle invasive bladder cancer in ...

Dr. Huang concluded this presentation discussing results of a phase II study of tislelizumab as neoadjuvant treatment for cisplatin-ineligible high-risk upper tract urothelial carcinoma with the ...

The responder rate, calculated as the proportion of subjects with ≥ 30% improvement in IPSS, was 74% at 36 months, similar to 75% at 12 months and 70% at 24 months. No deterioration in erectile or ...

Multiple case reports have discussed late repairs from 7 to 42 days with low rates of erectile dysfunction or penile curvature, albeit with short follow-up. Due ot the nature of the disease, there is ...

In a study from Dr. Zlotta’s group published in 2025 in the Journal of Urology, 1 they suggest that better tools are needed to minimize interobserver variability in pathological grading. This is ...

Leilane Glienke from the University of Michigan presented a study titled "Improved Control of Intrarenal Pressure Using a Prototype Fluid Management System Incorporating Ureteroscope Pressure Feedback ...

Patients treated with darolutamide who reached ultra-low PSA at any time had lower risk of radiological progression or death versus those with PSA >=0.2 ng/mL, with a risk reduction of 91%, as did ...

While MRI-targeted biopsy (TB) has improved prostate cancer detection, systematic biopsy (SB) remains a critical complementary approach, often identifying csPCa missed by TB. However, the optimal ...

Data was drawn from the Urology Residency Match (SAU Match) survey administered annually by the AUA. Participation remained strong across the three years, with 440, 428, and 387 applicants responding ...